Xavier Yon
NON-EXECUTIVE DIRECTOR
Elastagen
Australia
Biography
Xavier Yon is a seasoned healthcare executive with an extensive background in dermatology. Previous roles include executive positions with Pfizer, Solvay, Alcon and most notably as CEO of Galderma for 17 years. During his time at Galderma he built the company from its initial spin out from Alcon to be a world leader in ethical dermatology. Galderma currently has over 3,000 employees and $2 Billion in revenue. More recently Xavier has served as a Director of Graceway Pharmaceuticals (USA), which was acquired by Medicis in 2011. In addition to his position with Elastagen, Xavier currently serves as a board member of Photocure (Norway), a pioneer of Photo Dynamic Therapy, and Virbac (France), a global leader in animal health. Xavier holds a degree in Physics, Chemistry and Biology from Sorbonne University, Paris and attended the Advanced Management Program at Harvard University.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management
